238 related articles for article (PubMed ID: 7535490)
1. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
Barden N; Reul JM; Holsboer F
Trends Neurosci; 1995 Jan; 18(1):6-11. PubMed ID: 7535490
[TBL] [Abstract][Full Text] [Related]
2. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
Budziszewska B
Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
[TBL] [Abstract][Full Text] [Related]
3. Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
Barden N
J Psychiatry Neurosci; 1999 Jan; 24(1):25-39. PubMed ID: 9987205
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrinological mechanisms of actions of antidepressant drugs.
Schüle C
J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[TBL] [Abstract][Full Text] [Related]
6. Modulation of glucocorticoid receptor gene expression by antidepressant drugs.
Barden N
Pharmacopsychiatry; 1996 Jan; 29(1):12-22. PubMed ID: 8852529
[TBL] [Abstract][Full Text] [Related]
7. The hypothalamic-pituitary-adrenocortical (HPA) system and anti-depressive drug (AD) action.
Reul JM; Söder M; Holsboer F
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():584A-585A. PubMed ID: 1498962
[No Abstract] [Full Text] [Related]
8. The effects of antidepressants on the hypothalamic-pituitary-adrenal axis.
Mason BL; Pariante CM
Drug News Perspect; 2006 Dec; 19(10):603-8. PubMed ID: 17299602
[TBL] [Abstract][Full Text] [Related]
9. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
[TBL] [Abstract][Full Text] [Related]
11. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
12. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.
Barden N
J Psychiatry Neurosci; 2004 May; 29(3):185-93. PubMed ID: 15173895
[TBL] [Abstract][Full Text] [Related]
13. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
14. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
[TBL] [Abstract][Full Text] [Related]
15. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.
Holsboer F
J Psychiatr Res; 1999; 33(3):181-214. PubMed ID: 10367986
[TBL] [Abstract][Full Text] [Related]
16. Epiphenomenal, causal, or correlational--more on the mechanism(s) of action of antidepressants.
Shader RI; Fogelman SM; Greenblatt DJ
J Clin Psychopharmacol; 1998 Aug; 18(4):265-7. PubMed ID: 9690690
[No Abstract] [Full Text] [Related]
17. Partial glucocorticoid agonist-like effects of imipramine on hypothalamic-pituitary-adrenocortical activity, thymus weight, and hippocampal glucocorticoid receptors in male C57BL/6 mice.
Mukherjee K; Knisely A; Jacobson L
Endocrinology; 2004 Sep; 145(9):4185-91. PubMed ID: 15155572
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
Maric NP; Adzic M
Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
[TBL] [Abstract][Full Text] [Related]
19. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice.
Heydendael W; Jacobson L
Eur J Neurosci; 2010 Mar; 31(5):892-902. PubMed ID: 20374287
[TBL] [Abstract][Full Text] [Related]
20. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
